您好,欢迎来到上海士研管理咨询有限公司
产业峰会 演讲局 专家智库服务 峰会活动服务 整合营销服务
  • 产业峰会:
    以专业团队对产业和市场客观详实地调研为前提,拥有战略性、系统性、全球性的基因,汇集了领导者关注的热点话题与领袖代表,为您提供“一站式”的对话、分享、社交平台!
  • 演讲局:
    致力于为全球企业和机构提供主题演讲家、高管大师班、董事会顾问,每项服务都提供了一种更深入、更具互动性的体验,尤其是针对较小的精选受众和关键个人。我们拥有最具影响力的商业领袖和顶级专家的资源,他们是各自领域的最杰出的代表。我们的团队由经验丰富的演讲和活动经理组成,我们注重建立长期而深入的伙伴关系。
  • 专家智库服务:
    中国领先的行业专家知识信息服务供应商,为需要专业洞见的商业决策者匹配具有一手经验的行业专家,助力他们以更加明确的目标和坚定的信心做出决策。我们有60万余名专家顾问遍布二十多个行业,而且每天还在增加!
  • 峰会活动服务:
    致力于成为全球最专业的产业峰会活动提供商,为企业和机构的产业性峰会活动提供一站式专业服务,包括调研策划、定制邀请、营销推广、运营组织、项目管理、直播与数字化会议等,每项服务都由经验丰富的专业团队匹配长期沉淀的产业资源予以卓越执行,我们注重建立长期而深入的伙伴关系。
  • 整合营销服务:
    致力于成为全球领先的2B营销服务机构,聚焦产业高端活动、内容、渠道的建设与沉淀,为客户提供一站式整合营销解决方案,助力企业线上线下获客与品牌筑造。我们深信专业团队匹配产业资源带来卓越执行,我们注重建立长期而深入的伙伴关系。
嘉宾信息
发布时间: 2021 - 07 - 27
点击次数: 0
所属职位: 诉讼业务部合伙人Partner, Litigation Department
所属公司: 美国普衡律师事务所Paul Hastings
个人简介:
严妍是美国普衡律师事务所诉讼业务部合伙人,常驻上海代表处。她的主要业务领域包括生命科学、白领犯罪和内部调查、政府执法行动和争议解决,专门从事跨境合规和争议解决事务。严妍获准在纽约执业。她于2013年通过了中国律师资格考试,并拥有中国执业执照,但由于当地监管要求,该执照目前不处于有效状态。在加入普衡之前,她曾在一家提供全方位服务的中国律师事务所和一家国际律师事务所工作。Phoebe Yan is a litigation partner based in our Shanghai office. Her practice focuses on life science, white-collar crime and internal investigations, government enforcement actions, and dispute resolution. Ms. Yan specializes in cross-border compliance and contentious matters. Ms. Yan is admitted to practice law in New York. She also passed the bar in China in 2013 and has a Chinese practicing license, but the license is currently not in active status due to local regulatory requirements. Before joining Paul Hastings, Ms. Yan worked at a full-service Chinese law firm and an international law firm.
发布时间: 2021 - 07 - 27
点击次数: 0
所属职位: 诉讼业务部律师Of Counsel, Litigation Department
所属公司: 美国普衡律师事务所Paul Hastings
个人简介:
朱玉琦是美国普衡律师事务所诉讼业务部的一名顾问律师,于争议解决领域经验丰富,擅于处理涉及联合国国际贸易法委员会(UNCITRAL)、中国国际经济贸易仲裁委员会(CIETAC)、新加坡国际仲裁中心(SIAC)、香港国际仲裁中心(HKIAC)和国际商会(ICC)的国际仲裁,以及跨境诉讼。朱律师亦广泛参与合规事务,包括政府及内部调查、交易尽职调查、交易后合规计划的实施以及有关腐败、欺诈和制裁的风险评估。朱律师是香港的外地注册律师(纽约)。她亦已通过中国内地司法考试,并已在早前任职于一家中国顶级律师事务所期间获得了执业资格。Sarah Zhu is an Of counsel in the litigation department of Paul Hastings. Ms. Zhu has particular experience in dispute resolution through international arbitrations under UNCITRAL, CIETAC, SIAC, HKIAC and ICC and cross-border litigations. Ms. Zhu is also experienced in compliance matters including government and internal investigations, pre-transaction due diligence, post-transaction compliance program implementation, and risk assessment involving issues relating to corruption. fraud, and sanctions. Ms. Zhu is a Registered Foreign Lawyer (New York) in Hong Kong. She has also passed the PRC bar exam and had held a practicing license at the time when she was practicing at a top PRC law firm.
发布时间: 2021 - 08 - 02
点击次数: 0
所属职位: CEO
所属公司: 复星凯特生物科技有限公司
个人简介:
黄海先生2020年12月加入复星凯特生物科技有限公司担任CEO。公司立足于自主研发和技术转移相结合,致力于肿瘤免疫细胞治疗技术(CAR-T/TCR-T)在中国的产业化和规范化,造福中国患者。黄海先生在医药行业拥有近25年的丰富商业运营及国际化管理经验,曾先后在辉瑞、赛诺菲、罗氏诊断和美敦力等跨国药企任职。加入复星凯特前,担任辉瑞普强首席运营官(COO),曾在2018年打造了中国首个年销售额达12亿美元的单产品;并在带量采购的大环境下,积极发展公司未来战略,布局互联网医疗。Mr. Huang Hai joined Fosun Kite Biotechnology Co., Ltd. (FSK in short) as CEO in December 2020. Based on the combination of independent R&D and technology transfer, FSK is committed to the industrialization and standardization of tumor immune cell therapy technology (CAR-T/TCR-T) in China to benefit Chinese patients. Mr. Huang Hai has nearly 25 years of experience in commercial operations and international management in the pharmaceutical industry. He has worked in multinational pharmaceutical companies such as Pfizer, Sanofi, Roche Diagnostics and Medtronic. Prior to joining FSK, he served as the Chief Operating Officer (COO) of Upjohn China. In 2018, he created China’s first single product with annual sales of US$1.2 billion; and in the environment of mass procurement, he actively developed Upjohn’s future strategy and deployed Internet medical services.
发布时间: 2021 - 08 - 02
点击次数: 0
所属职位: 高级副总裁及首席商务官
所属公司: 上海药明巨诺生物科技有限公司
个人简介:
吴琼先生于2020年9月8日加入药明巨诺,担任高级副总裁兼首席商务官,全面负责公司的商业团队和商业化运营管理工作。吴琼深耕医疗健康行业26年,曾领导多个药物及器械品牌取得杰出的市场表现。加入药明巨诺之前,吴琼在默沙东中国担任医院专科业务董事总经理。此前,他还曾就职于百特中国、西安杨森等领先的医药健康企业,并取得了多项卓越成果:领导科素亚在中国市场的快速成长,使其获得市场领先地位;推动了保列治在中国市场的业绩增长,并使其成为默沙东全球市场的业绩冠军;与原国家卫生部合作,共同推动腹膜透析疗法在中国的发展,令百特中国的医院产品部扭亏为盈。吴琼拥有中欧国际工商学院高级管理人员工商管理硕士(EMBA)学位和中国药科大学药物分析专业学士学位。 Mr. Alex Wu joined JW Therapeutics on September 8, 2020, as Senior Vice President (SVP) and Chief Commercial Officer (CCO) and is in charge of the overall commercial function and operations.  Mr. Wu has been in the healthcare industry for 26 years. Before joining JW Therapeutics, Mr. Wu was an Assistant Vice President (AVP) and General Manager of Hospital Specialty Business in MSD China. Prior to that, he has worked in Baxter China, Xian Janssen, and Danone China. During his tenure, he has achieved the following outstanding results: Led the first region to launch Cozaar and made it a market leader; Accelerated the growth of Proscar in the Chinese market to surpass both UK and US markets to be the No.1 in MSD globally; Built a win-win partnership with the Ministry of Health (now known as the National Health Commission of the PRC) to promote the peritoneal dialysis (PD) therapy together in China, and turned around Baxter China’s hospital products (HP) business into a profitable and sustainable one.   Mr. Wu received his Bachelor’s degree in Medical Analysis from China Pharmaceutical University and an EMBA (Executive Master of Business Administration) degree from China Europe International Business School (CEIBS).
微信公众号
领导者网络APP
友情链接
Copyright ©2005 - 2017上海士研管理咨询有限公司
犀牛云提供企业云服务